In a report released on March 14, Matthew Biegler from Oppenheimer reiterated a Buy rating on Allogene Therapeutics (ALLO – Research Report), ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

Expedia Group (NASDAQ:EXPE – Free Report) had its price objective trimmed by Oppenheimer from $235.00 to $230.00 in a ...

In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

Fueled by DOGE’s tactics, many car buyers -- particularly those who identify as liberal or connected with the Democratic Party, the opposition to Trump’s Republicans -- appear to have begun ratcheting ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...

Remembering Pat, a good friend from Omaha, Neb.

Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...